Design of the Weight-loss Endoscopy Trial (WET) : a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure

  • Background: Obesity is a global problem leading to reduced life expectancy, cardiovascular diseases, diabetes and many types of cancer. Even people willing to accept treatment only achieve a mean weight loss of about 5 kg using commercial weight loss programs. Surgical interventions, e.g. sleeve gastrectomy or gastric bypass are effective but accompanied by risk of serious complications and side effects. Less invasive endoscopic procedures mainly comprise the intragastric balloon (IB) and the duodenal-jejunal bypass liner (DJBL). To date, a randomized comparison between these devices has not been undertaken or shown to be superior to a sham procedure. Methods: We designed a multi-center, randomized, patient and assessor-blinded, controlled trial comparing weight loss in endoscopically implanted IB vs. DJBL vs. a sham procedure. A total of 150 patients with a BMI > 35 kg/m2 or > 30 with obesity-related comorbidities and indication for proton pump inhibitors are randomized to receive either IB, DJBL or a sham gastroscopy (2:2:1 ratio). All participants undergo regular dietary consultation. The IB will be removed after 6 months, whereas the DJBL will be explanted after 12 months. All patients will receive gastroscopies at implantation and explantation of the devices or sedation without gastroscopy to maintain blinding. Main exclusion criteria are malignant diseases, peptic ulcer or previous bariatric intervention. Weight loss 12 months after explantation of the devices, changes in comorbidities, quality of life, complication rates and safety will be evaluated. Discussion: This trial could help to identify the most effective and safest endoscopic device, thus determining the new standard procedure for endoscopic bariatric treatment. Trial registration: 16th January 2017. DRKS00011036. Funded by the German Research Foundation (DFG).

Download full text files

Export metadata

Metadaten
Author:Marcus HollenbachORCiDGND, Christiane Prettin, Felix GundlingORCiDGND, Wolfgang ScheppORCiD, Jochen SeufertORCiDGND, Jürgen SteinORCiDGND, Thomas RöschGND, Jens AberleGND, Jürgen FeisthammelGND, David Petrof, Albrecht HoffmeisterGND
URN:urn:nbn:de:hebis:30:3-476974
DOI:https://doi.org/10.1186/s12876-018-0838-3
ISSN:1471-230X
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/30021518
Parent Title (English):BMC gastroenterology
Publisher:BioMed Central
Place of publication:London
Contributor(s):Tiffany Schaumburg
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/07/18
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2018/10/18
Tag:Bypass liner; Diabetes; Endoscopy; Intragastric balloon; Obesity; Weight loss
Volume:18
Issue:Art. 118
Page Number:8
First Page:1
Last Page:8
Note:
Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
HeBIS-PPN:439186013
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0